We’re In The News

As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.

Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.

New Blood Tests for Early Cancer Detection Get Some Love From House Members

MedPage Today, September 18, 2025: This news article describes Energy & Commerce Health Committee hearing on bills that would require Medicare cover Breakthrough devices and controversial Multi-cancer Screening tests. NCHR president Dr. Diana Zuckerman testified, describing the cancer tests as “not ready for prime time” and explaining that the latest research shows they are very inaccurate, with some having a false positive rate over 90%

FDA Leaders Moving to Abandon Advisory Committee Reviews of Specific New Drugs

STAT News, September 12, 2025: FDA seeks to abandon Advisory Committees for specific drugs and use them for bigger issues says CDER head George Tidmarsh. We point out that Expert Panels are also replacing Advisory Committees with one-sided reviews.

The Business of Pet Adoption

The Times-Journal (Alabama), September 5, 2025: Pets play a leading role in many people’s lives. Researchers tell us that companion animals (pets) improve human health and well-being. For example, pets can help lower blood pressure, improve heart health, have fewer sick days, and get more exercise.

FDA Expert Panels Lack Balance in Pursuit of ‘Gold Standard Science’

BioSpace, September 8, 2025: NCHR’s Dr. Diana Zuckerman tells BioSpace that the new FDA expert panels, such as those on SSRI’s during pregnancy and hormone therapy for menopause are more biased than FDA Advisory Committees and lack nuance about complicated data. They send a message to industry about what changes FDA wants to make.

After 10 Years, the FDA Is Still Letting Women Down

Drugwatch, August 14, 2025: This excellent article explains that FDA lets women down when they approve drugs and devices for cancer and many other serious diseases, which often don’t work well on women and can be harmful. The article quotes Dr. Diana Zuckerman and other experts, and provides examples of specific medical products that you may have used or want to avoid.